Compare ITRN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRN | FLGT |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 854.8M | 697.3M |
| IPO Year | 2005 | 2016 |
| Metric | ITRN | FLGT |
|---|---|---|
| Price | $44.04 | $26.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $50.00 | $28.33 |
| AVG Volume (30 Days) | 109.9K | ★ 272.3K |
| Earning Date | 11-18-2025 | 11-07-2025 |
| Dividend Yield | ★ 4.52% | N/A |
| EPS Growth | ★ 8.81 | N/A |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $348,409,000.00 | $315,549,000.00 |
| Revenue This Year | $9.12 | $16.84 |
| Revenue Next Year | $10.70 | $9.74 |
| P/E Ratio | $15.57 | ★ N/A |
| Revenue Growth | 5.20 | ★ 13.61 |
| 52 Week Low | $28.96 | $14.57 |
| 52 Week High | $45.43 | $31.04 |
| Indicator | ITRN | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 72.82 | 45.08 |
| Support Level | $39.24 | $26.69 |
| Resistance Level | $44.92 | $31.04 |
| Average True Range (ATR) | 1.14 | 0.74 |
| MACD | 0.43 | -0.45 |
| Stochastic Oscillator | 82.48 | 7.13 |
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.